Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SAIHEAT Announces Receipt of Notification from Nasdaq
-
InnovAge Provides Update on Clinical & Operational Transformations at National PACE Association Annual Conference
-
Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week
-
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Michelin : Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
Auron Announces Poster Presentation at 2024 PCF Annual Scientific Retreat
-
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
-
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
-
Better Choice Company to Expand into Veterinary Medicine in 2025 Following the Acquisition of SRx Health
-
Gate.io Will List PUFFER for Trading and Simultaneously Launch PUFFER Mining, with a Total Amount of 1,500,000 Tokens
-
WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE GOLD 3X DAILY SHORT SECURITIES ISIN: IE00B6X4BP29
-
Man Group PLC : Form 8.3 - AngloGold Ashanti plc
-
Man Group PLC : Form 8.3 - International Paper Company
-
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting
-
Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology
-
U.S. Energy Corp. Regains Full Compliance with Nasdaq Listing Standards
-
AGBA ADVANCES TOWARD COMPLETION OF THE TRILLER MERGER
-
Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology
-
ATHA Energy Announces Option Agreements With Terra Uranium for Spire, Horizon, and Pasfield Projects
-
OTC Markets Group Welcomes Concord Acquisition Corp II to OTCQX
-
Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 25, 2024
-
Acquisition of The Sempre Group Holdings Ltd
-
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting
-
Jo-Jo Capital Canada Ltd. Announces Termination of Proposed Qualifying Transaction
-
DSV, 1140 - MAJOR SHAREHOLDER ANNOUNCEMENT
-
Community Associations Institute Seeks Preliminary Injunction Against Corporate Transparency Act
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
Net Asset Value(s)
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
K92 Mining 2024 Third Quarter Financial Results Conference Call Details
-
Equifax Canada Appoints Ramon Yarde as Chief Data Officer
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
ACHC Accreditation of DirectRx Pharmacy Recognizes High Level of Patient Care
-
MARTELA CORPORATION: DISCLOSURE UNDER CHAPTER 9, SECTION 10 OF THE SECURITIES MARKET ACT
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Keywords Studios plc
-
Share buy-back programme at SP Group A/S
-
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
-
LiveOne (NASDAQ: LVO) Partners With METAvivor to Fund Metastatic Breast Cancer Research, Live Streaming #LightUpMBC Live on October 13, 2024
-
Red Cat Ships Teal-2 Drones to Florida Army National Guard to Assist with Hurricane Milton Disaster Response
-
Constellium to Report Third Quarter 2024 Results on October 23, 2024
-
Unity Bancorp Reports Quarterly Earnings of $10.9 Million
-
Worldline - Monthly information relating to the total number of voting rights and shares making up the share capital on 30 September 2024
-
Decisions of Innofactor Plc’s Extraordinary General Meeting and the organizing meeting of the Board of Directors
-
THE CHIEF EXECUTIVE OFFICER OF AB „KN ENERGIES“ HAS BEEN ELECTED
-
EBC Financial Group Enhances Liquidity and Lowers Trading Costs on Major Stock Indices
-
Form 8.3 - Equals Group PLC
-
AS Pro Kapital Grupp announces the partial early redemption of unsecured bonds
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SEGRO plc - Ordinary Shares
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GRAN TIERRA ENERGY INC
